Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
Go back to Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting| LIPOCINE (NASDAQ: LPCN) | Delayed: 2.29 -0.04 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $14.80 | |||
| Open | $2.30 | 52 Week Low | $2.51 | |||
| Day High | $2.54 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $-0.69 | |||
| Volume | 93,893 | |||||
